Skip to main content
SpringerLink
Log in

Concomitant Therapy and Autonomic Tests

  • Chapter
Book cover Clinical Guide to Cardiac Autonomic Tests

  • 173 Accesses

Abstract

There is an increasing awareness of the role played by the autonomic nervous system in a diversity of cardiovascular diseases.1,2 Autonomic tests were initially developed to improve our understanding of physiological and pathophysiological mechanisms in humans and animals. They subsequently evolved to become clinical tests that can be used in everyday practice.3,4

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Barron HV, Lesh MD. Autonomic nervous system and sudden cardiac death. JArn Coll Cardiol 1996; 27: 1053–1060.

    Article  CAS  Google Scholar 

  2. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992; 20: 248–254.

    Article  PubMed  CAS  Google Scholar 

  3. van Ravenswaaij-Arts CMA, Kollée LAA, Hopman JCW, Stcelinga GBA, van Geijn HP. Heart rate variability. Ann bit Med 1993; 118: 436–447.

    Google Scholar 

  4. Le Heuzey JY. La variabilité sinusale: intérêt en rythmologie. Arch Mal Coeur 1992; 85: 37–43.

    PubMed  Google Scholar 

  5. Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 1985; 8: 491–498.

    Article  PubMed  CAS  Google Scholar 

  6. Smyth HS, Sleight P, Pickering GW. Reflex regulation of arterial pressure during sleep in man: a quantitative method of assessing baroreflex sensitivity. Circ Res 1969; 24: 109–121.

    Article  PubMed  CAS  Google Scholar 

  7. Billman GE, Schwartz PJ, Stone HL. Baroreceptor reflex control of heart rate: a predictor of sudden cardiac death. Circulation 1982; 66: 874–880.

    Article  PubMed  CAS  Google Scholar 

  8. Farrell TG, Paul V, Cripps TR, Malik M, Bennett ED, Ward D, Camm AJ. Baroreflex sensitivity and electrophysiological correlates in patients after acute myocardial infarction. Circulation 1991; 83: 945–952.

    Article  PubMed  CAS  Google Scholar 

  9. Sayers B Mc A. Analysis of heart rate variability. Ergonomics 1973; 16: 85–97.

    Article  Google Scholar 

  10. Wolf MM, Varigos GA, Hunt D, Sloman JG. Sinus arrhythmia in acute myocardial infarction. Med JAust 1978; 2: 52–53.

    CAS  Google Scholar 

  11. Akselrod S, Gordon D, Ubel FA, Shannon DC, Barger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuations: a quantitative probe of beat-tobeat cardiovascular control. Science 1981; 213: 220–222.

    Article  PubMed  CAS  Google Scholar 

  12. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ, and the Multicenter Post-Infarction Research Group. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 59: 256–262.

    Article  Google Scholar 

  13. Farrel TG, Bashir Y, Cripps T, Malik M, Poloniecki J, Bennett ED, Ward DE, Camm AJ. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Ain Coll Cardiol 1991; 18: 687–697.

    Article  Google Scholar 

  14. Copie X, Hnatkova K, Staunton A, Lü Fei, Camm AJ, Malik M. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. A two-year follow-up study. JArn Coll Cardiol 1996; 27: 270–276.

    Article  CAS  Google Scholar 

  15. Copie X, Hnatkova K, Lü Fei, Staunton A, Camm AJ, Malik M. Gender specificities in risk stratification after myocardial infarction. Ann Noninuas Electrocardiol 1997; 2: 59–68.

    Article  Google Scholar 

  16. Casolo GC, Stroder P, Signorini C, Calzolari F, Zucchini M, Balli E, Sulla A, Lazzerini S. Heart rate variability during the acute phase of myocardial infarction. Circulation 1992; 85: 2073–2079.

    Article  PubMed  CAS  Google Scholar 

  17. Schwartz PJ, Zaza A, Pala M, Locati E, Beria G, Zanchetti A. Baroreflex sensitivity and its evolution during the first year after myocardial infarction. JAmn Coll Cardiol 1988; 12: 629–636.

    Article  CAS  Google Scholar 

  18. Copie X, Le Heuzey JY, Iliou MC, Pousset F, Lavergne T, Guize L. Evolution de la variabilité de la fréquence cardiaque après infarctus du myocarde. Apport du diagramme de Poincaré. Arch Mal Cceur 1995, 88: 1621–1626.

    CAS  Google Scholar 

  19. Sharpey-Schafer EP. Effects of Valsalva’s manoeuvre on the normal and failing circulation. Br Med J 1955; 1: 693–695.

    Article  PubMed  CAS  Google Scholar 

  20. Prichard BNC, Gillam MS. Propranolol in hypertension. Am J Cardiol 1966; 387–391.

    Google Scholar 

  21. ISIS-1 (First International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 1988; 1: 921–923.

    Google Scholar 

  22. CIBIS Investigators and Committees. A randomized trial of (3-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 1994; 90: 1765–1573.

    Article  Google Scholar 

  23. Leon DF, Shaver JA, Leonard JJ. Reflex heart rate control in man. Am Heart J 1970; 80: 729–739.

    Article  PubMed  CAS  Google Scholar 

  24. Spodick DH, Meyer MB, Quarry-Pigott VM. Effect of ß-adrenergic blockade on beat-to-beat response to Valsalva maneuver. Br Heart J 1974; 36: 1082–1086.

    Article  PubMed  CAS  Google Scholar 

  25. Hoshino PK, Blaustein AS, Gaasch WH, Johnson A. Effect of propranolol on left ventricular response to the Valsalva maneuver in normal subjects. Am J Cardiol 1988; 61: 400–404.

    Article  PubMed  CAS  Google Scholar 

  26. Bennett T, Wilcox RG, Hampton JR. Cardiovascular reflexes in patients after myocardial infarction. Effects of long-term treatment with 13adrenoreceptor antagonists. Br Heart J 1980; 44: 265–270.

    Article  PubMed  CAS  Google Scholar 

  27. Zoller RP, Mark AL, Abboud FM, Schmid PG, Heistad DD. The role of low pressure baroreceptors in reflex vasoconstrictor responses in man. J Clin Invest 1972; 51: 2967–2972.

    Article  PubMed  CAS  Google Scholar 

  28. Ferguson DW, Thames MD, Mark AL. Effects of propranolol on reflex vascular responses to orthostatic stress in humans. Role of ventricular baroreceptors. Circulation 1983; 67: 802–807.

    Article  PubMed  CAS  Google Scholar 

  29. Sra JS, Murthy VS, Jazayeri MR, Shen YE, Troup PJ, Avitall B, Akhtar M. Use of intravenous esmolol to predict efficacy of oral beta-adrenergic blocker therapy in patients with neurocardiogenic syncope. J Am Coll Cardiol 1992; 19: 402–408.

    Article  PubMed  CAS  Google Scholar 

  30. Müller G, Deal BJ, Stasburger JF, Benson DW. Usefulness of metoprolol for unexplained syncope and positive response to tilt testing in young persons. Ain J Cardiol 1993; 71: 592–595.

    Article  Google Scholar 

  31. Cohen MB, Snow JS, Grasso V, Lehnert L, Goldner BG, Jadonath RL, Cohen TJ. Efficacy of pindolol for treatment of vasovagal syncope. Am Heart J 1995; 130: 786–790.

    Article  PubMed  CAS  Google Scholar 

  32. Jhamb DK, Singh B, Sharda B, Kaul U, Goel P, Talwar KK, Wasir HS. Comparative study of the efficacy of metoprolol and verapamil in patients with syncope and positive head-up tilt test response. A, n Heart J 1996; 132: 608–611.

    Article  CAS  Google Scholar 

  33. Bristow JD, Honour AJ, Pickering GW, Sleight P, Smyth HS. Diminished baroreflex sensitivity in high blood pressure. Circulation 1969; 39: 48–54.

    Article  PubMed  CAS  Google Scholar 

  34. Eckberg DL, Drabinsky M, Braunwald E. Defective cardiac parasympathetic control in patients with heart disease. New Engl JMed 1971; 285: 877–883.

    Article  CAS  Google Scholar 

  35. Eckberg DL, Sleight P. Baroreflex malfunction in cardiovascular patients: general principles. In: Eckberg DL, Sleight P (Eds) Human baroreflexes in health and disease. Oxford University Press, New York 1992, 303–326.

    Google Scholar 

  36. Pickering TG, Gribbin B, Strange Petersen E, Cunnigham DJC, Sleight P. Effects of autonomic blockade on the baroreflex in man at rest and during exercise. Circ Res 1971; 30: 177–185.

    Article  Google Scholar 

  37. Eckberg DL, Abboud FM, Mark AL. Modulation of carotid baroreflex responsiveness in man: effects of posture and propranolol. J Appl Physiol 1976; 41: 383–387.

    PubMed  CAS  Google Scholar 

  38. Simon G, Kiowski W, Julius S. Effect of beta adrenoreceptor antagonists on baroreceptor reflex sensitivity in hypertension. Clin Pharrn Therap 1977; 22: 293–298.

    CAS  Google Scholar 

  39. Takeshita A, Tanaka S, Nakamura M. Effects of propranolol on baroreflex sensitivity in borderline hypertension. Cardiovasc Res 1978; 12: 148–151.

    Article  PubMed  CAS  Google Scholar 

  40. Krediet RT, Dunning AJ. Baroreflex sensitivity in hypertension during betaadrenergic blockade. Br Heart J 1979; 41: 106–110.

    Article  PubMed  CAS  Google Scholar 

  41. Watson RDS, Stallard TJ, Littler WA. Effects of ß-adrenoreceptor antagonists on sino-aortic baroreflex sensitivity and blood pressure in hypertensive men. Clin Sci1979; 57: 241–247.

    Google Scholar 

  42. Takata S, Ogawa J, Okuwa H, Yagi S, Iwase N, Hattori N. Effect of propranolol on baroreflex control of heart rate in young patients with essential hypertension. Angiology 1986; 37: 106–111.

    Article  PubMed  CAS  Google Scholar 

  43. Floras JS, Vann Jones J, Hassan MO, Sleight P. Effects of acute and chronic ß-adrenoreceptor blockade on baroreflex sensitivity in humans. J Auton Nery Syst 1988; 25: 87–94.

    Article  CAS  Google Scholar 

  44. Malik M, Camm AJ. Heart rate variability and clinical cardiology. Br Heart J 1994; 71: 3–6.

    Article  PubMed  CAS  Google Scholar 

  45. Binder T, Frey B, Porenta G, Heinz G, Wutte M, Kreiner G, Gössinger H, Schmidinger H, Pacher R, Weber H. Prognostic value of heart rate variability in patients awaiting cardiac transplantation. Pacing Clin Electrophys 1992; 15: 2215–2220.

    Article  CAS  Google Scholar 

  46. van Hoogenhuyze D, Weistein N, Martin GJ, Weiss JS, Schaad JW, Sahyouni N, Fintel D, Remme WJ, Singer DH. Reproducibility and relation to mean heart rate of heart rate variability in normal subjects and in patients with congestive heart failure secondary to coronary artery disease. Ant J Cardiol 1991; 68: 1668–1676.

    Article  Google Scholar 

  47. Coumel P, Maison-Blanche P, Catuli D. Heart rate and heart rate variability in normal young adults. J Cardiovasc Electrophysiol 1994; 5: 899–911.

    Article  PubMed  CAS  Google Scholar 

  48. Coker R, Koziell A, Oliver C, Smith SE. Does the sympathetic nervous system influence sinus arrhythmia in man? Evidence from combined autonomic blockade. J Physiol 1984; 356: 459–464.

    PubMed  CAS  Google Scholar 

  49. Pomeranz B, Macaulay RJB, Caudill MA, Kutz I, Adam D, Gordon D, Kilborn KM, Barger C, Shannon DC, Cohen RJ, Benson H. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 1985; 248: H151–H153.

    PubMed  CAS  Google Scholar 

  50. Pagani M, Lombardi F, Guzzetti S, Rimoldi 0, Furlan R, Pizzinelli P, Sandrone G, Malfatto G, Dell’Orto S, Piccaluga E, Turiel M, Baselli G, Cerutti S, Malliani A. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 1986; 59: 178–193.

    Article  PubMed  CAS  Google Scholar 

  51. Bekheit S, Tangella M, el-Sakr A, Rasheed Q, Craelius W, el-Sherif N. Use of heart rate spectral analysis to study the effects of calcium channel blockers on sympathetic activity after myocardial infarction. Am Heart J 1990; 119: 79–85.

    Article  PubMed  CAS  Google Scholar 

  52. Coumel Ph, Hermida JS, Wennerblöm B, Leenhardt A, Maison-Blanche P, Cauchemez B. Heart rate variability in myocardial hypertrophy and heart failure, and effects of beta-blocking therapy: A non-spectral analysis of heart rate oscillations. Eur Heart J 1991; 65: 1345–1350.

    Google Scholar 

  53. Cook JR, Bigger JT, Kleiger RE, Fleiss JL, Steinman AB, Rolnitzky LM. Effect of atenolol and diltiazem on heart period variability in normal persons. JAu’ Coll Cardiol 1991; 17: 480–484.

    Article  CAS  Google Scholar 

  54. Molgaard H, Mickley H, Pless P, Bjerregaard P, Moller M. Effects of metoprolol on heart rate variability in survivors of acute myocardial infarction. Am J Cardiol 1993; 71: 1357–1359.

    Article  PubMed  CAS  Google Scholar 

  55. Hohnloser SH, Klingenheben T, Zabel M, Just H. Effect of sotalol on heart rate variability assessed by Holter monitoring in patients with ventricular arrhythmias. Am J Cardiol 1993; 72: 67A–71A.

    Article  PubMed  CAS  Google Scholar 

  56. Niemela MJ, Airaksinen KEJ, Huikuri HV. Effect of 13-blockade on heart rate variability in patients with coronary artery disease. J Am Coll Cardiol 1994; 23: 1370–1377.

    Article  PubMed  CAS  Google Scholar 

  57. Ahmed MW, Kadish AH, Parker MA, Goldberger JJ. Effect of physiologic and pharmacologic adrenergic stimulation on heart rate variability. J Am Coll Cardiol 1994; 24: 1082–1090.

    Article  PubMed  CAS  Google Scholar 

  58. Pitzalis MV, Mastropasqua F, Massari F, Totaro P, Passantino A, Rizzon P. The effect of nadolol on heart rate and the standard deviation of the RR intervals. Eur Heart J 1995; 16: 269–275.

    PubMed  CAS  Google Scholar 

  59. Kontopoulos AG, Athyros VG, Papageorgiou AA, Papadopoulos GV, Avramidis MJ, Boudoulas H. Effect of quinapril or metoprolol on heart rate variability in post-myocardial infarction patients. Am J Cardiol 1996; 77: 242–246.

    Article  PubMed  CAS  Google Scholar 

  60. Copie X, Pousset F, Lechat Ph, Jaillon P, Guize L, Le Heuzey JY, and CIBIS investigators. Effects of (3-blockade with bisoprolol on heart rate variability in patients with advanced heart failure: analysis of scatterplots of RR intervals at selected heart rates. Am Heart J 1996; 132: 369–375.

    Article  PubMed  CAS  Google Scholar 

  61. Pousset F, Copie X, Lechat Ph, Jaillon P, Boissel JP, Hetzel M, Remme W, Guize L, Le Heuzey JY. Effects of bisoprolol on heart rate variability in heart failure. Am J Cardiol 1996; 77: 612–617.

    Article  PubMed  CAS  Google Scholar 

  62. Keeley EC, Lange RA, Hillis D, Joglar JA, Page RL. Correlation between time-domain measures of heart rate variability and scatterplots in patients with healed myocardial infarcts and the influence of metoprolol. Am J Cardiol 1997; 79: 412–414.

    Article  PubMed  CAS  Google Scholar 

  63. Bigger TJ, Kleiger RE, Fleiss JL, Rolnitzky LM, Steinman RC, Miller JP. Components of heart rate variability measured during healing of acute myocardial infarction. Am J Cardiol 1989; 61: 208–215.

    Article  Google Scholar 

  64. Zuanetti G, Neilson JMM, Latini R, Santoro E, Maggioni AP, Ewing DJ, on behalf of GISSI-2 Investigators. Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era. The Gissi-2 results. Circulation 1996; 94: 432–436.

    Article  PubMed  CAS  Google Scholar 

  65. Adamson PB, Huang MH, Vanoli E, Foreman RD, Schwartz PJ, Hull SS. Unexpected interaction between ß-adrenergic blockade and heart rate variability before and after myocardial infarction. A longitudinal study in dogs at high and low risk for sudden death. Circulation 1994; 90: 976–982.

    Article  PubMed  CAS  Google Scholar 

  66. Hartikainen JEK, Malik M, Staunton A, Poloniecki J, Camm AJ. Predictive power of heart rate variability used as a stratifier of cardiac mortality after myocardial infarction in patients discharged with and without beta-blocker therapy. Annals Noninvas Electrocard 1996; 1: 12–18.

    Article  Google Scholar 

  67. Copie X, Le Heuzey JY, Iliou MC, Khouri R, Lavergne T, Pousset F, Guize L. Correlation between time-domain measures of heart rate variability and scatterplots in post-infarction patients. PACE 1996; 19: 342–347.

    Article  PubMed  CAS  Google Scholar 

  68. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429–1435.

    Article  Google Scholar 

  69. The ISIS-4 Collaborative group. International Study of Infarct Survival-4. A randomized trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulfate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995; 345: 669–685.

    Article  Google Scholar 

  70. Levine TB, Olivari MT, Garberg V, Sharkey SW, Cohn JN. Hemodynamic and clinical response to enalapril, a long acting converting-enzyme inhibitor, in patients with congestive heart failure. Circulation 1984; 69: 548–553.

    Article  PubMed  CAS  Google Scholar 

  71. Cody RJ, Bravo EL, Fouad FM, Tarazi RC. Cardiovascular reflexes during chronic converting enzyme inhibition and sodium depletion: the response to tilt in hypertensive patients. Am JMed 1981; 71: 422–426.

    Google Scholar 

  72. Ebert TJ. Captopril potentiates chronotropic baroreflex responses to carotid stimuli in humans. Hypertension 1985; 7: 602–606.

    Article  PubMed  CAS  Google Scholar 

  73. Campbell BC, Sturani A, Reid JL. Evidence of parasympathetic activity of an angiotensin-converting enzyme inhibitor captopril in normotensive men. Clin Sci 1985; 68: 49–56.

    PubMed  CAS  Google Scholar 

  74. Osterziehl KJ, Rohring N, Dietz R, Manthey J, Hecht J, Kuber W. Influence of captopril on the arterial baroreceptor reflex in patients with heart failure. Eur Heart J 1988; 9: 1137–1145.

    Google Scholar 

  75. Vogt A, Unterberg C, Kreuzer H. Acute effects of the new angiotensin converting enzyme inhibitor ramipril on hemodynamics and carotid sinus baroreflex activity in congestive heart failure. Am J Cardiol 1987; 59: 149D–154D.

    Article  PubMed  CAS  Google Scholar 

  76. Volpe M, Lembo G, Condorelli G, De Luca N, Lamenza F, Indolfi C, Trimarci B. Converting enzyme inhibition prevents the effects of atrial natriuretic factor on baroreflex responses in humans. Circulation 1990; 82: 1214–1221.

    Article  PubMed  CAS  Google Scholar 

  77. Osterziehl KJ, Dietz R, Schmid W, Mikulaschek K, Kuber W. ACE inhibition improves vagal activity in patients with heart failure. Am Heart J 1990; 120: 1120–1129.

    Article  Google Scholar 

  78. Bonaduce D, Petretta M, Morgano G, Attisano T, Bianchi V, Arrichiello P, Rotondi F, Condorelli M. Effects of converting enzyme inhibition on baroreflex sensitivity in patients with myocardial infarction. J Am Coll Cardiol 1992; 20: 587–593.

    Article  PubMed  CAS  Google Scholar 

  79. Flapan AD, Nolan J, Neilson JMM, Ewing DJ. Effect of captopril on parasympathetic activity in chronic cardiac failure secondary to coronary artery disease. Am J Cardiol 1992; 69: 532–535.

    Article  PubMed  CAS  Google Scholar 

  80. Binkley PF, Haas JG, Starling RC, Nunziata E, Hatton PA, Leier CV, Cody RJ. Sustained augmentation of parasympathetic tone with angiotensinconverting enzyme inhibition in patients with congestive heart failure. JAin Coll Cardiol 1993; 21: 655–661.

    Article  CAS  Google Scholar 

  81. Kaufman ES, Bosner MS, Bigger JT, Stein PK, Kleiger RE, Rolnitzky LM, Steinman RC, Fleiss JL. Effects of digoxin and enalapril on heart period variability and response to head-up tilt test in normal subjects. Am J Cardiol 1993; 72: 95–99.

    Article  PubMed  CAS  Google Scholar 

  82. Bonaduce D, Marciano F, Petretta M, Migaux ML, Morgano G, Bianchi V, Salemme L, Valva G, Condorelli M. Effects of converting enzyme inhibition on heart period variability in patients with acute myocardial infarction. Circulation 1994; 90: 108–113.

    Article  PubMed  CAS  Google Scholar 

  83. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Pozzi M, Morganti A, Carugo S, Mancia G. Effects of chronic ACE inhibition on sympathetic nerve trafic and baroreflex control of circulation in heart failure. Circulation 1997; 96: 1173–1179.

    Article  PubMed  CAS  Google Scholar 

  84. Lyons D, Roy S, O’Byrne S, Swift CG. ACE Inhibition. Postsynaptic adrenergic sympatholytic action in men. Circulation 1997; 96: 911–915.

    Article  PubMed  CAS  Google Scholar 

  85. Noll G, Wenzel RR, de Marchi S, Shaw S, Löscher TF. Differential effects of captopril and nitrates on muscle sympathetic nerve activity in volunteers. Circulation 1997; 95: 2286–2292.

    Article  PubMed  CAS  Google Scholar 

  86. Dibner-Dunlap ME, Smith ML, Kinugawa T, Thames MD. Enalapril augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure. J Am Coll Cardiol 1996; 27: 358–364.

    Article  PubMed  CAS  Google Scholar 

  87. Scroop GC, Lowe RD. Central pressor effect of angiotensin mediated by parasympathetic nervous system. Nature 1968; 220: 1331–1335.

    Article  PubMed  CAS  Google Scholar 

  88. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525–533.

    Article  Google Scholar 

  89. Chai CY, Wang HH, Hoffman BF, Wang SC. Mechanisms of bradycardia induced by digitalis substances. Am J Physiol 1967; 212: 26–34.

    PubMed  CAS  Google Scholar 

  90. Ten Eick RE, Hoffman BF. The effect of digitalis on the excitability of autonomic nerves. J Pharrnacol Exp Ther 1969; 169: 95–108.

    Google Scholar 

  91. Quest JA, Gillis RA. Carotid sinus reflex changes produced by digitalis. J Pharrnacol Exp Ther 1971: 177: 650–661.

    CAS  Google Scholar 

  92. Quest JA, Gillis RA. Effect of digitalis on carotid sinus baroreceptor activity. Circ Res 1974; 35: 247–255.

    Article  CAS  Google Scholar 

  93. Gillis RA, Pearle DL, Levitt O. Digitalis: a neuroexcitatory drug. Circulation 1975; 52: 739–741.

    Article  PubMed  CAS  Google Scholar 

  94. Cokkinos DV, Haralambakis AG, Thalassinos NC, Heìnomas ET, Demopoulos JN, Voridis EM, Gardikas CD. Effects of digitalis on diminished baroreceptor sensitivity in diabetics. Angiology 1979; 30: 549–557.

    Article  PubMed  CAS  Google Scholar 

  95. Gillis RA, Quest JA. The role of the nervous system in the cardiovascular effects of digitalis. Pharrnacol Rev 1980; 31: 19–97.

    Google Scholar 

  96. Ferrari A, Gregorini L, Ferrari MC, Preti L, Mancia G. Digitalis and baroreceptor reflexes in man. Circulation 1981; 63: 279–285.

    Article  PubMed  CAS  Google Scholar 

  97. Ferrari A, Bonazzi O, Gregorini L, Gardumi M, Perondi R, Mancia G. Modification of the baroreceptor control of atrio-ventricular conduction induced by digitalis in man. Cardiovasc Res 1983; 17: 633–641.

    Article  PubMed  CAS  Google Scholar 

  98. Thames MD, Miller BD, Abboud FM. Sensitization of vagal cardiopulmonary baroreflex by chronic digoxin. Am J Physiol 1982; 243: H815–H818.

    PubMed  CAS  Google Scholar 

  99. Ferguson DW, Berg WJ, Sanders JS, Roach PJ, Kempf JS, Kienzle MG. Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings. Circulation 1989; 80: 65–77.

    Article  PubMed  CAS  Google Scholar 

  100. Krum H, Bigger JT, Goldsmith RL, Packer M. Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure. J Am Coll Cardiol 1995; 25: 289–294.

    Article  PubMed  CAS  Google Scholar 

  101. McLain PL. Effects of cardiac glycosides on spontaneous efferent activity in vagus and sympathetic nerves of cats. bit J Neuropharrnacol 1969; 8: 379–387.

    CAS  Google Scholar 

  102. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 321: 406–412.

    Article  Google Scholar 

  103. Cairns JA, Connolly SJ, Roberts R, Gent M, for the Canadian Amiodarone Myocardial Infarction Arrhytmia Trial Investigators. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 1997; 349: 675–682.

    Article  PubMed  CAS  Google Scholar 

  104. Sopher M, Camm AJ. Adverse effects of amiodarone at low dose: Plus ca change. JAin Coll Cardiol 1997; 30: 799–801.

    Article  CAS  Google Scholar 

  105. Alboni P. Paparella N, Cappato R, Candini GC. Direct and automatically mediated effects of oral flecainide. Am J Cardiol 1988; 61: 759–763.

    Article  PubMed  CAS  Google Scholar 

  106. Alboni P, Paparella N. Vagolytic effect of propafenone (letter). Am Heart J 1988; 116: 1648.

    Article  PubMed  CAS  Google Scholar 

  107. Zuanetti G, Latini R, Neilson JMN, Schwartz PJ, Ewing DJ, and the antiarrhythmic drug evaluation group (ADEG). Heart rate variability in patients with ventricular arrhythmias: effect of antiarrhythmic drugs. J Ain Coll Cardiol 1991; 17: 604–612.

    Article  Google Scholar 

  108. Lombardi F, Torzillo D, Sandrone G, Dalla Vecchia L, Cappiello E. Beta-blocking effect of propafenone based on spectral analysis of heart rate variability. Ain J Cardiol 1992; 70: 1028–1034.

    Article  CAS  Google Scholar 

  109. Lombardi F, Torzillo D, Sandrone G, Dalla Vecchia L, Cappiello E. Autonomic effects of antiarrhythmic drugs and their importance. Eur Heart J 1992; 13: F38–F43.

    Article  Google Scholar 

  110. Packer M. Pathophysiological machanisms underlying the adverse effects of calcium channel-blocking drugs in patients with chronic heart failure. Circulation 1989; 80: 59–67.

    Google Scholar 

  111. Adinoff B, Mefford I, Waxman R, Linnoila M. Vagal tone decreases following intravenous diazepam. Psychiatry Res 1992; 41: 89–97.

    Article  PubMed  CAS  Google Scholar 

  112. Lund-Johansen P, Omvik P. Haemodynamic effects of nifedipine in essential hypertension at rest and during exercise. J Hypertension 1983; 1: 159–163.

    Article  CAS  Google Scholar 

  113. Kiowski W, Erne O, Bolli P, Bühler F. Acute and chronic sympathetic reflex activation and antihypertensive response to nifedipine. J Am Coll Cardiol 1986; 7: 344–348.

    Article  PubMed  CAS  Google Scholar 

  114. Lown B, Verrier RL. Neural activity and ventricular fibrillation. N Engl J Med 1976; 294: 1165–1170.

    Article  PubMed  CAS  Google Scholar 

  115. Vanoli E, De Ferrari GM, Stramba-Badiale M, Hull SS, Foreman RD, Schwartz PJ. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res 1991; 68: 1471–1481.

    Article  PubMed  CAS  Google Scholar 

  116. De Ferrari GM, Vanoli E, Curcuruto P, Tommasini G, Schwartz PJ. Prevention of life-threatening arrhythmias by pharmacologic stimulation of the muscarinic receptors with oxotremorine. Ain Heart J 1992; 124: 883–890.

    Article  Google Scholar 

  117. Mc Closkey DI. Cardiorespiratory integration. In: Levy MN, Schwartz PJ (Eds) Vagal Control of the Heart: Experimental Basis and Clinical Implications. Futura, Armonk 1994, 481–508.

    Google Scholar 

  118. Wetzel GT, Brown JH. Presynaptic modulation of acetylcholine release from cardiac parasympathetic neurons. Am JPhysiol 1985; 248: H146–H151.

    Google Scholar 

  119. Hull SS, Vanoli E, Adamson PB, De Ferrari GM, Foreman RD, Schwartz PJ. Do increases in markers of vagal activity imply protection from sudden death? The case of scopolamine. Circulation 1995; 91: 2516–2519.

    Article  PubMed  CAS  Google Scholar 

  120. Raczkowska M, Eckberg DL, Ebert TJ. Muscarinic cholinergic receptors modulate vagal cardiac responses in man. J Anton New Syst 1983; 7: 271–278.

    Article  CAS  Google Scholar 

  121. Dibner-Dunlap ME, Eckberg DL, Magid NM, Cintrón-Trevino NM. The long term increase of baseline and reflexly augmented levels of human vagal-cardiac nervous activity induced by scopolamine. Circulation 1985; 71: 797–804.

    Article  PubMed  CAS  Google Scholar 

  122. Vybiral T, Bryg RJ, Maddens ME, Bhasin SS, Cronin S, Boden WE, Lehmann MH. Effects of transdermal scopolamine on heart rate variability in normal subjects. Am J Cardiol 1990; 65: 604–608.

    Article  PubMed  CAS  Google Scholar 

  123. Raeder EA, Stys A, Cohen RJ. Effect of low-dose scopolamine on autonomic control of the heart. Ann Noninvas Electrocard 1997; 2: 236–241.

    Article  CAS  Google Scholar 

  124. Casadei B, Pipilis A, Sessa F, Conway J, Sleight P. Low doses scopolamine increase vagal tone in the acute phase of myocardial infarction. Circulation 1993; 88: 353–357.

    Article  PubMed  CAS  Google Scholar 

  125. Pedretti R, Colombo E, Braga SS, Carù B. Influence of transdermal scopolamine on cardiac sympathovagal interaction after acute myocardial infarction. Am J Cardiol 1993; 72: 384–392.

    Article  Google Scholar 

  126. De Ferrari GM, Mantica M, Vanoli E, Hull SS, Schwartz PJ. Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction. JAm Coll Cardiol 1993; 22: 1327–1334.

    Article  Google Scholar 

  127. Vybiral T, Glaeser DH, Morris G, Hess KR, Yang K, Francis M, Pratt CM. Effects of low dose transdermal scopolamine on heart rate variability in acute myocardial infarction. JAm Coll Cardiol 1993; 22: 1320–1326.

    Article  CAS  Google Scholar 

  128. Pedretti RFE, Colombo E, Braga SS, Ballardini L, Carù B. Effects of oral pirenzepine on heart rate variability and baroreceptor reflex sensitivity after acute myocardial infarction. JAm Coll Cardiol 1995; 25: 915–921.

    Article  CAS  Google Scholar 

  129. La Rovere MT, Mortara A, Pantaleo P, Mestri R, Cobelli F, Tavazzi L. Scopolamine improves autonomic balance in advanced congestive heart failure. Circulation 1994; 90: 838–843.

    Article  PubMed  Google Scholar 

  130. Sleight P, West MJ, Korner PI, Oliver JR, Chalmers JP, Robinson JL. The action of clonidine on the baroreflex control of heart rate in conscious animals and man, and on single aortic baroreceptor discharge in the rabbit. Arch Int Pharmacodyn 1975; 214: 4–11.

    PubMed  CAS  Google Scholar 

  131. Pedretti RFE, Colombo E, Braga SS, Carù B. Effect of thrombolysis on heart rate variability and life-threatening ventricular arrhythmias in survivors of acute myocardial infarction. JAm Coll Cardiol 1994; 23: 19–26.

    Article  CAS  Google Scholar 

  132. Bonaduce D, Petretta M, Piscione F, Indolfi C, Migaux ML, Bianchi V, Esposito N, Marciano F, Chiarello M. Influence of reversible segmental left ventricular dysfunction on heart period variability in patients with one-vessel coronary artery disease. JAm Coll Cardiol 1994; 24: 399–405.

    Article  CAS  Google Scholar 

  133. Yeragani VK, Pohl R, Balon R. Effect of imipramine treatment on heart rate variability measures. Neuropsychobiology 1992; 26: 27–32.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Xavier Copie
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Louis Guize
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jean-Yves Le Heuzey
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Cardiological Sciences, St. George’s Hospital Medical School, London, UK

    Marek Malik

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Copie, X., Guize, L., Le Heuzey, JY. (1998). Concomitant Therapy and Autonomic Tests. In: Malik, M. (eds) Clinical Guide to Cardiac Autonomic Tests. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-1057-2_12

Download citation

  • DOI: https://doi.org/10.1007/978-94-017-1057-2_12

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-90-481-5071-7

  • Online ISBN: 978-94-017-1057-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation